These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation. Barr ML; Sanchez JA; Seche LA; Schulman LL; Smith CR; Rose EA Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387 [TBL] [Abstract][Full Text] [Related]
5. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients. Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608 [TBL] [Abstract][Full Text] [Related]
6. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine. Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426 [TBL] [Abstract][Full Text] [Related]
7. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study. Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040 [TBL] [Abstract][Full Text] [Related]
8. Triple-drug immunosuppression for heart transplantation in infants and children. Brown JW; Turrentine MW; Kesler KA; Mahomed Y; Darragh R; Evans K; Thompson L; Caldwell R J Heart Lung Transplant; 1993; 12(6 Pt 2):S265-74. PubMed ID: 8312346 [TBL] [Abstract][Full Text] [Related]
9. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. Olivari MT; Jessen ME; Baldwin BJ; Horn VP; Yancy CW; Ring WS; Rosenblatt RL J Heart Lung Transplant; 1995; 14(1 Pt 1):127-35. PubMed ID: 7727461 [TBL] [Abstract][Full Text] [Related]
10. Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation. Keogh A; Macdonald P; Mundy J; Chang V; Harvison A; Spratt P J Heart Lung Transplant; 1992; 11(3 Pt 1):550-5; discussion 556. PubMed ID: 1610863 [TBL] [Abstract][Full Text] [Related]
11. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
13. Low-dose ciclosporin, prednisone, and azathioprine after initial immunosuppression with ciclosporin and prednisone in a pediatric renal transplant population. Turner MC Child Nephrol Urol; 1990; 10(3):125-30. PubMed ID: 2285916 [TBL] [Abstract][Full Text] [Related]
14. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study. Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242 [TBL] [Abstract][Full Text] [Related]
15. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience. Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007 [TBL] [Abstract][Full Text] [Related]